Match Document Document Title
US20110224910 METHODS OF NORMALIZING MEASURED DRUG CONCENTRATIONS AND TESTING FOR NON-COMPLIANCE WITH A DRUG TREATMENT REGIMEN  
Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In one embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing...
US20150066379 COMPUTER SYSTEM AND APPARATUS FOR DETERMINING SENSITIVITY TO BREAST CANCER NEOADJUVANT CHEMOTHERAPY  
Sensitivity to breast cancer neoadjuvant chemotherapy is determined on the basis of a result of analysis of the expression level, by amplifying RNA extracted from a specimen collected from a...
US20140039036 Methods for Identifying Subjects with a Genetic Risk for Developing IgA Nephropathy  
Seven protective alleles for IgA nephropathy have been discovered that can be identified by analyzing a DNA sample for seven respective SNPs. A method is provided for identifying and treating...
US20120178118 BIOMARKERS FOR MONITORING TREATMENT OF NEUROPSYCHIATRIC DISEASES  
Methods for identifying and measuring pharmacodynamic biomarkers of neuropsychiatric disease, and for monitoring a subject's response to treatment.
US20140348818 BIOMARKERS OF KAWASAKI DISEASE  
Biomarkers of Kawasaki Disease (KD) are provided. In certain aspects, methods are provided for detecting KD biomarkers, such as elevated PDGFC expression. Likewise, methods of treating a subject...
US20140147875 DISEASE SEVERITY INDEX FOR ASSESSMENT OF CHRONIC LIVER DISEASE AND METHOD FOR DIAGNOSIS OF THREE DISTINCT SUBTYPES OF PRIMARY SCLEROSING CHOLANGITIS  
A Disease Severity Index (DSI) is provided for assessment of chronic liver disease in a patient using non-invasive liver function test results. A DSI was derived from non-invasive liver function...
US20150012225 INFERRING A STATE OF A SYSTEM OVER TIME  
The present disclosure relates to a method, apparatus, system and computer program for inferring a system state over time. Biomedical measurement data is obtained, wherein the data relate to at...
US20110161013 METHOD FOR DETERMINING HEAT BOUNDARY VALUE CONDITIONS OF RED BLOOD CELLS IN THE NEIGHBORHOOD OF MYOCARDIUM  
A computer-implemented method for determining heat boundary value conditions of red blood cells neighboring a myocardium pertaining to the left ventricle of a heart. The method comprises dividing...
US20130130933 BIOMARKER SIGNATURES FOR WELLNESS TESTING  
This invention generally relates to the use of devices to measure and assess the level of biomarkers that are indicative of the general wellness of an individual and methods of correlating such...
US20130274136 PROSTATE CANCER POINT OF CARE DIAGNOSTICS  
The invention relates to point of care diagnostic disposables, devices, methods, and systems for diagnosing or predicting prostate cancer. The present invention employs biomarker specific reagents...
US20110151481 BETA-2 MICROGLOBULIN AS A BIOMARKER FOR PERIPHERAL ARTERY DISEASE  
The present invention provides β2 microglobulin as a biomarker for qualifying or assessing peripheral artery disease in a subject.
US20140343865 Biomarkers for Kidney Cancer and Methods Using the Same  
Methods for identifying and evaluating biochemical entities useful as biomarkers for kidney cancer, target identification/validation, and monitoring of drug efficacy are provided. Also provided...
US20150142329 METHOD AND SYSTEM FOR EXERCISE MONITORING  
A portable data processing system includes a memory system, a processing system and a reception system for receiving data from acceleration sensors indicating test subject's acceleration in three...
US20130138355 METHOD AND SYSTEM FOR EVALUATING SEQUENCES  
A method of evaluating correlation between sequences by employing a hierarchy of evaluation algorithms. The evaluation algorithms may be arranged in order of computational efficiency as specified...
US20130124099 SECONDARY STRUCTURE DEFINING DATABASE AND METHODS FOR DETERMINING IDENTITY AND GEOGRAPHIC ORIGIN OF AN UNKNOWN BIOAGENT THEREBY  
The present invention relates generally to the field of investigational bioinformatics and more particularly to secondary structure defining databases. The present invention further relates to...
US20120123685 SECONDARY STRUCTURE DEFINING DATABASE AND METHODS FOR DETERMINING IDENTITY AND GEOGRAPHIC ORIGIN OF AN UNKNOWN BIOAGENT THEREBY  
The present invention relates generally to the field of investigational bioinformatics and more particularly to secondary structure defining databases. The present invention further relates to...
US20110238316 SECONDARY STRUCTURE DEFINING DATABASE AND METHODS FOR DETERMINING IDENTITY AND GEOGRAPHIC ORIGIN OF AN UNKNOWN BIOAGENT THEREBY  
The present invention relates generally to the field of investigational bioinformatics and more particularly to secondary structure defining databases. The present invention further relates to...
US20110172925 Secondary Structure Defining Database And Methods For Determining Identity And Geographic Origin Of An Unknown Bioagent Thereby  
The present invention relates generally to the field of investigational bioinformatics and more particularly to secondary structure defining databases. The present invention further relates to...
US20150218640 BIOMARKER SIGNATURE METHOD, AND APPARATUS AND KITS THEREFOR  
The present invention discloses methods, kits, and apparatus as well as reagents and compositions associated therewith for deriving an indicator for use in diagnosing the presence, absence or...
US20070083333 Modeling of systemic inflammatory response to infection  
Models for the systemic inflammatory response to infection, which involve the use of immunocompromised animals, and methods of using the models are described. These models can be used in...
US20120220477 GENETIC MARKERS ASSOCIATED WITH RISK OF DIABETES MELLITUS  
The invention relates to variants that predispose to risk of type 2 diabetes, basal cell carcinoma and breast cancer. It has been discovered that certain genetic variants confer risk of these...
US20120278000 METHOD FOR ASSESSING EFFICACY OF COMBINATION CHEMOTHERAPY, AND PROGRAM AND DEVICE FOR ASSESSING THE SAME  
A method for assessing an efficacy of combination chemotherapy, comprising: a first obtaining process for obtaining a specific activity value of Cyclin Dependent Kinase (CDK) 1 and a specific...
US20150094227 PREGNANCY TEST DEVICE AND METHOD  
Disclosed is a test device to detect pregnancy in a human female subject, the test device comprising: an assay means to measure the absolute or relative amount of hCG in a sample from the...
US20140039803 Method for Rapid Identification of Drug Targets and Drug Mechanisms of Action in Human Cells  
A method of identification of drug targets and drug resistance mechanisms in human cells of a drug comprising the steps of: generating at least one drug-resistant sample and at least one...
US20110077870 BLOOD CELL COUNTER, DIAGNOSIS SUPPORT METHOD AND COMPUTER PROGRAM PRODUCT  
A blood cell counter apparatus comprising: a detector for detecting blood cells in blood of a subject; and a controller for obtaining, based on a detection result by the detector, first analytical...
US20150160223 METHOD OF PREDICTING NON-RESPONSE TO FIRST LINE CHEMOTHERAPY  
The invention provides a method for determining a prognosis of colorectal cancer in a colorectal cancer patient, comprising classifying said patient as having a good prognosis or a poor prognosis...
US20150186606 METHOD AND DEVICE FOR INDICATING DIFFERENTIATION BETWEEN TISSUES  
The present invention provides a method for indicating differentiation between tissues. For each tissue amongst multiple tissues, a magnetization vector corresponding to each tissue is generated...
US20070198193 Automatic creation and identification of biochemical pathways  
An information management system for managing biochemical information comprises data structures for modelling biochemical entities (616), categories (606) and biochemical pathways (600)....
US20110118986 METHODS AND APPARATUS FOR EVALUATING GLUCOSE LEVELS AROUND A REPEATING EVENT  
Methods for evaluating changes in glucose levels include selecting a repeating event, obtaining a pre-event measurement and a post-event measurement for a plurality of occurrences of the repeating...
US20100324827 Fluid Responsiveness Measure  
A method and system for measuring fluid responsiveness of a patient is disclosed. Information related to fluid responsiveness of a patient may be derived from a PPG signal, for example, by...
US20130260384 METHOD FOR DETERMINING CANCER PROGNOSIS AND PREDICTION WITH CANCER STEM CELL ASSOCIATED GENES  
Disclosed herein is a general method of formulating a cancer diagnosis or prognosis test based on a cancer stem cell (CSC)-associated gene expression signature, the method include steps of...
US20110021566 GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS  
Methods for predicting whether iloperidone will be efficacious in treating a psychotic symptom in an individual, based on the individual's genotype at one or more single nucleotide polymorphism...
US20150147770 EMBRYO QUALITY ASSESSMENT BASED ON BLASTOCYST DEVELOPMENT  
The present invention relates to a method and to a system for selecting embryos for in vitro fertilization based on observed cell kinetics and cell morphology. One embodiment of the invention...
US20090177147 INSULIN PUMP WITH INSULIN THERAPY COACHING  
An apparatus comprising a pump configured to deliver insulin, an input configured to receive information related to managing diabetes of a user, a user interface, and a controller communicatively...
US20120309639 Compositions and Methods for Diagnosing Genome Related Diseases and Disorders  
Compositions, methods, and kits for diagnosing genetic disorders such as type I diabetes are disclosed.
US20120065893 Method and apparatus for mitigating aviation risk by determining cognitive effectiveness from sleep history  
Method and apparatus for analyzing and managing fatigue primarily in but not limited to aviation occupations. The invention is adaptable to other occupations where assuring crew rest is critical....
US20060160135 SF-1 and LRH-1 modulator development  
Structures of SF1 and LRH are described, along with methods for identifying or developing modulators of those receptors and uses for such modulators.
US20140222349 System and Methods for Pharmacogenomic Classification  
The invention provides a system and methods for the determination of the pharmacogenomic phenotype of any individual or group of individuals, ideally classified to a discrete, specific and defined...
US20140276166 METHOD OF MEASURING BIOIMPEDANCE  
A method for measuring the impedance of a portion of a subject, by passing a known current provided by a current source unit between a first pair of electrodes contacting the skin surface of the...
US20150120205 SYSTEM AND METHOD FOR MANAGING STRESS  
A device for managing user stress is provided. The device includes a collection unit that collects stress related information, an analysis unit that determines a stress state, and an expression...
US20140249761 CHARACTERIZING UNCHARACTERIZED GENETIC MUTATIONS  
An ensemble predictor for characterizing uncharacterized genetic mutations is disclosed. A first set of genomic information representing a particular (e.g., harmful) mutation is obtained. The...
US20150193587 DIABETES-RELATED BIOMARKERS AND METHODS OF USE THEREOF  
The invention describes biomarkers which can be used to predict the likelihood that an individual will develop Diabetes. The biomarkers can also be used to screen large groups in order to identify...
US20140147850 DIABETES-RELATED BIOMARKERS AND METHODS OF USE THEREOF  
The invention describes biomarkers which can be used to predict the likelihood that an individual will develop Diabetes. The biomarkers can also be used to screen large groups in order to identify...
US20120179484 DIABETES-RELATED BIOMARKERS AND METHODS OF USE THEREOF  
The invention describes biomarkers which can be used to predict the likelihood that an individual will develop Diabetes. The biomarkers can also be used to screen large groups in order to identify...
US20130332082 MULTI-PARAMETER DIABETES RISK EVALUATIONS  
Methods, systems and circuits evaluate a subject's risk of developing type 2 diabetes or developing or having prediabetes using at least one defined mathematical model of risk of progression that...
US20120197535 Methods for identifying bacteria  
The present invention provides methods for identifying bacteria by analysis of lipid A and/or lipoteichoic acid structure and/or mass spectrometry ionization patterns.
US20140315317 DISK-TYPE MICROFLUID SYSTEM AND METHOD FOR CHECKING BLOOD STATUS  
A method for checking blood status comprises: a step of supplying blood to the centrifuge container of a disk; a step of rotating the disk to centrifuge the blood into blood cells and blood plasma...
US20110182872 METHODS OF ANALYSIS OF POLYMORPHISMS AND USES THEREOF  
The present invention provides methods for the assessment of diseases that result from the combined or interactive effects of two or more genetic variants, and in particular for diagnosing risk of...
US20100304369 METHOD AND APPARATUS FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION  
Disclosed is a method for identifying an individual who has an altered risk for developing age-related macular degeneration comprising detecting an insertion/deletion polymorphism in the ARMS2 gene
US20130013219 Determining Susceptibility To A Sudden Cardiac Event  
Disclosed herein is a method of do terming the likelihood of a sudden cardiac event, such as an arrythmia, in a subject. Also disclosed is a method of determining whether a subject is at risk of a...